Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer
- 31 December 1992
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 28 (8-9) , 1315-1318
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 1990
- A genetic model for colorectal tumorigenesisCell, 1990
- Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniquesBreast Cancer Research and Treatment, 1989
- Cell kinetics as a prognostic indicator in node-negative breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Regulation of Cathepsin-D and pS2 Gene Expression by Growth Factors in MCF7 Human Breast Cancer CellsMolecular Endocrinology, 1989
- Breast Cancer-Associated pS2 Protein: Synthesis and Secretion by Normal Stomach MucosaScience, 1988
- Review: Steroid Receptors, Cellular Kinetics, and Lymph Node Status as Prognostic Factors in Breast CancerThe American Journal of the Medical Sciences, 1988
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958